» Articles » PMID: 264694

A Soluble ATP-dependent Proteolytic System Responsible for the Degradation of Abnormal Proteins in Reticulocytes

Overview
Specialty Science
Date 1977 Jan 1
PMID 264694
Citations 149
Authors
Affiliations
Soon will be listed here.
Abstract

Reticulocytes, like other cells, selectively degrade certain abnormal proteins by an energy-dependent process. When isolated rabbit reticulocytes incorporate the valine analog 2-amino-3chlorobutyric acid (ClAbu) in place of valine, they produce an abnormal globin that is degraded with a half-life of 15 min. Normal hemoglobin, in contrast, undergoes little or no breakdown within these cells. Cell-free extracts from reticulocytes have been shown to rapidly hydrolyze these abnormal proteins. The degradative system is located in the 100,000 X g supernatant, has a pH optimum of 7.8, and does not appear to be of lysosomal origin. This breakdown of analog-containing protein was stimulated severalfold by ATP, and slightly by ADP. AMP and adenosine-3':5'-cyclic monophosphate had no significant effect on proteolysis. Experiments with ATP analogs suggest that the terminal high energy phosphate is important in the degradative process. Proteolysis in the cell-free system and in intact reticulocytes was inhibited by the same agents (L-l-tosylamido-2-phenyl-ethylchloromethyl ketone, N-alpha-p-tosyl-L-lysine chloromethyl ketone, N-ethylmaleimide, iodoacetamide, and o-phenanthroline). In addition, the relative rates of degradation of several polypeptides in the cell-free extracts paralleled degradatives rates within cells. Thus, a soluble nonlysosomal proteolytic system appears responsible for the energy-dependent degradation of abnormal proteins in reticulocytes.

Citing Articles

Comparative Analysis of Acquired Resistance to Bortezomib in Prostate Cancer Cells Using Proteomic and Bioinformatic Tools.

Seker S, Sahin B, Yerlikaya A J Cell Mol Med. 2025; 29(1):e70254.

PMID: 39799471 PMC: 11725179. DOI: 10.1111/jcmm.70254.


Selective protein degradation through chaperone‑mediated autophagy: Implications for cellular homeostasis and disease (Review).

Huang J, Wang J Mol Med Rep. 2024; 31(1).

PMID: 39513615 PMC: 11542157. DOI: 10.3892/mmr.2024.13378.


Different Strategies to Overcome Resistance to Proteasome Inhibitors-A Summary 20 Years after Their Introduction.

Tyrna P, Procyk G, Szeleszczuk L, Mlynarczuk-Bialy I Int J Mol Sci. 2024; 25(16).

PMID: 39201634 PMC: 11354503. DOI: 10.3390/ijms25168949.


Structure, Function, and Allosteric Regulation of the 20S Proteasome by the 11S/PA28 Family of Proteasome Activators.

Thomas T, Salcedo-Tacuma D, Smith D Biomolecules. 2023; 13(9).

PMID: 37759726 PMC: 10526260. DOI: 10.3390/biom13091326.


Targeted Protein Degradation: Principles and Applications of the Proteasome.

Kim Y, Kim E, Chey Y, Song M, Jang H Cells. 2023; 12(14).

PMID: 37508510 PMC: 10378610. DOI: 10.3390/cells12141846.


References
1.
Rabinovitz M, Fisher J . CHARACTERISTICS OF THE INHIBITION OF HEMOGLOBIN SYNTHESIS IN RABBIT RETICULOCYTES BY THREO-ALPHA-AMINO-BETA-CHLOROBUTYRIC ACID. Biochim Biophys Acta. 1964; 91:313-22. DOI: 10.1016/0926-6550(64)90255-5. View

2.
Rannels D, Kao R, Morgan H . Effect of insulin on protein turnover in heart muscle. J Biol Chem. 1975; 250(5):1694-701. View

3.
Prouty W, GOLDBERG A . Effects of protease inhibitors on protein breakdown in Escherichia coli. J Biol Chem. 1972; 247(10):3341-52. View

4.
GOLDBERG A . Correlation between rates of degradation of bacterial proteins in vivo and their sensitivity to proteases. Proc Natl Acad Sci U S A. 1972; 69(9):2640-4. PMC: 427006. DOI: 10.1073/pnas.69.9.2640. View

5.
Meister A . On the enzymology of amino acid transport. Science. 1973; 180(4081):33-9. DOI: 10.1126/science.180.4081.33. View